STUDY OF CARDIOPROTECTIVE AND ANTI-ISCHEMIC EFFECTIVENESS OF STANDARD TREATMENT FOR ISCHEMIC HEART DISEASE WITH ADDITION OF PERINDOPRIL ARGININE, IN OLDER PATIENTS

STUDY OF CARDIOPROTECTIVE AND ANTI-ISCHEMIC EFFECTIVENESS OF STANDARD TREATMENT FOR ISCHEMIC HEART DISEASE WITH ADDITION OF PERINDOPRIL ARGININE, IN OLDER PATIENTS

Aim. To evaluate the cardioprotective, anti-ischemic and vasoprotective effectiveness of perindopril arginine (Prestarium А®, Les Laboratories Servier, France) in stable angina patients of older age, after myocardial infarction (MI).Material and methods. Totally, 68 patients of older age (72±12 y.)...

Full description

Bibliographic Details
Main Authors:	L. F. Maksyutova, A. F. Maksyutova, G. M. Bikkinina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2016-03-01
Series:	Российский кардиологический журнал
Subjects:	stable angina postinfarction cardiosclerosis perindopril arginin
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/739

Similar Items

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

TAURIN INFLUENCE ON CLINICAL COURSE OF STAbLE ANGINA IN POSTINFARCTION CARDIOSCLEROSIS PATIENTS
by: I. S. Vasilieva, et al.
Published: (2018-05-01)

Фармакоэпидемиология постинфарктного кардиосклероза и приверженноть больных лечению
by: О. Н. Курочкина, et al.
Published: (2011-04-01)

GENDER DIFFERENCES OF CORONARY HEART DISEASE PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND CHRONIC MITRAL REGURGITATION BY THE DATA OF CORONARY ANGIOGRAPHY REGISTRY
by: E. I. Yaroslavskaya, et al.
Published: (2014-08-01)

Perindopril arginine: a new ACE inhibitor salt increases therapeutic potential
by: Yu. A. Karpov
Published: (2008-12-01)

FEATURES OF DYSLIPOPROTEINEMIA IN TYPE 2 DIABETES MELLITUS PATIENTS WITH PRIOR MYOCARDIAL INFARCTION
by: N.V. Altunina
Published: (2020-09-01)

State of Left Ventricular Systolic and Diastolic Function in Patients with Postinfarction Cardiosclerosis and Obesity
by: P.P. Kravchun
Published: (2014-09-01)

THE INFLUENCE OF LONG-TERM THERAPY WITH PERINDOPRIL ON THE HEART INOTROPIC FUNCTION IN PATIENTS WITH CHRONIC POSTINFARCTION ANEURISM
by: I. G. Fomina, et al.
Published: (2016-01-01)

Plastic processes at ischemic injury of myocardium and role of local mitogens in its regeneration (according to the results of researches made in Scientific Center of Reconstructive and Restorative Surgery SB RAMS)
by: N. I. Arsentyeva, et al.
Published: (2014-05-01)

ACHIEVEMENT OF ARTERIAL HYPERTENSION CONTROL VIA APPLICATION OF PERINDOPRIL ARGININE AND AMLODIPINE COMBINATION
by: O. N. Kryuchkova, et al.
Published: (2015-12-01)

Low-dose combination of perindopril arginine with indapamide in correction of metabolic syndrome
by: Svetlana Igorevna Kseneva, et al.
Published: (2011-10-01)

IMPROVEMENT OF AMLODIPINE CONTROL EFFICACY OVER HYPERTENSION USING FIXED COMBINATION OF PERINDOPRIL ARGININE AND AMLODIPINE
by: O. N. Kryuchkova, et al.
Published: (2015-05-01)

Quality of Life of Patients with Stable Coronary Artery Disease Combined with Non-Alcoholic Fatty Liver Disease
by: Iryna Vakalyuk, et al.
Published: (2016-12-01)

EFFECTIVENESS OF PHARMACOTHERAPY FOR NORMALIZATION OF THE BRAIN NATRIURETIC PEPTIDE, RENINE-ANGIOTENSINALDOSTERONE SYSTEM ACTIVATION AFTER SURGICAL REVASCULARIZATION OF MYOCARDIUM IN POSTINFARCTION CARDIOSCLEROSIS PATIENTS
by: S. A. Kovalev, et al.
Published: (2016-12-01)

FUNCTIONAL STATE OF MYOCARDIUM AFTER APPLICATION OF A NON-CELLULAR ALLOGENIC MATERIAL FOR STIMULATION OF REGENERATION CAPACITY IN EXPERIMENTAL INFARCTION
by: S. A. Afanasiev, et al.
Published: (2018-04-01)

Structural and Functional Changes of the Myocardium in Case of Comorbidity of Postinfarction Cardiosclerosis and Type 2 Diabetes
by: Kravchun P.
Published: (2014-09-01)

Disturbances of Cardiohaemodynamics, Heart Rhythm, Lipid, Purine Metabolism and Systemic Inflammation and Efficiency of Their Correction in Patients with Postinfarction Cardiosclerosis, Associated with Hyperuricemia
by: Lypovetska S.
Published: (2017-09-01)

Time course of changes in brachial artery function in patients with unstable angina pectoris during perindopril therapy
by: Ia B Khovaeva, et al.
Published: (2012-09-01)

Angiographic equivalents of stable angina in patients with coronary atherosclerosis and myocardial infarction
by: A. I. Koryakov
Published: (2005-10-01)

Influence of L-carnitine on reactive oxygen species production by blood phagocytes in postinfarction cardiosclerosis patients
by: E. I. Astashkin, et al.
Published: (2016-10-01)

Permeability of the Perindopril Arginine under In Vitro Conditions across Caco-2 Monolayer and Biomimetic Phospholipid Membrane
by: Czaklosz, P., et al.
Published: (2022)

Permeability of the Perindopril Arginine under In Vitro Conditions across Caco-2 Monolayer and Biomimetic Phospholipid Membrane
by: Czaklosz, P., et al.
Published: (2022)

Antihypertensive Effectiveness of Perindopril Arginine and Indapamide Single-Pill Combination According to Body Mass Index: Findings from the FORSAGE Study
by: M. G. Glezer, et al.
Published: (2020-02-01)

Gender and Age Characteristics of Cardiac Remodeling in Patients with Postinfarction Cardiosclerosis, Diabetes Mellitus Type 2 and Obesity
by: P.P. Kravchun
Published: (2015-03-01)

Antihypertensive efficacy of a fixed full-dose perindopril A-indapamide combination in patients with grades 2–3 arterial hypertension
by: T V Glukhova, et al.
Published: (2013-03-01)

Epidemiology, Pathophysiology, and Therapeutic Targets in Stable Ischemic Heart Disease
by: C. Richard Conti, MD, MACC
Published: (2019-01-01)

Fixed-dose combination of amlodipine/indapamide/perindopril arginine — a rational and safe choice for blood pressure control in actual clinical setting: data of an observational program DOKAZATEL`STVO
by: J. D. Kobalava, et al.
Published: (2020-07-01)

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT
by: N. A. Shostak, et al.
Published: (2009-12-01)

UHPLC-UV Method for Simultaneous Determination of Perindopril Arginine and Indapamide Hemihydrate in Combined Dosage Form: A Stability-Indicating Assay Method
by: Naser F. Al-Tannak
Published: (2018-02-01)

Gene polymorphism of aldosterone synthetase (CYP11B2) variants and main cardiovascular risk factors
by: L. Ye. Lobach, et al.
Published: (2016-12-01)

Perindopril and a Galectin-3 Inhibitor Improve Ischemic Heart Failure in Rabbits by Reducing Gal-3 Expression and Myocardial Fibrosis
by: Sha Li, et al.
Published: (2019-03-01)

Sudden Cardiac Death in Adult Patients with Stable Ischemic Heart Disease
by: C. Richard Conti, MD, MACC
Published: (2019-01-01)

Method development and validation of HPLC tandem/mass spectrometry for quantification of perindopril arginine and amlodipine besylate combination in bulk and pharmaceutical formulations
by: Kalaiyarasi Duraisamy, et al.
Published: (2017-01-01)

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension
by: A. G Evdokimova, et al.
Published: (2016-06-01)

Perindopril/amlodipine-induced thrombotic microangiopathy
by: Vlatka Perisa, et al.
Published: (2021-01-01)

BLOOD PRESSURE VARIABILITY AS A NEW TARGET FOR ANTIHYPERTENSIVE THERAPY: FOCUS ON THE FIXED COMBINATION OF AMLODIPINE AND PERINDOPRIL ARGININ
by: V. M. Gorbunov
Published: (2012-10-01)

Pathomorphological predictors of left heart ventricle dilatation at ischemic cardiomyopathy patients with chronic cardiac decompensation in postoperative period
by: V. A. Kazakov, et al.
Published: (2004-12-01)

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease
by: O. A. Vartanova, et al.
Published: (2008-06-01)

A rare cause of pediatric acute pancreatitis: Perindopril intoxication
by: Merve Misirlioglu, et al.
Published: (2020-01-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)